Navigation Links
Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
Date:10/6/2008

- Data Presented at ACG Annual Scientific Conference -

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Ironwood Pharmaceuticals (formerly Microbia) today announced presentation of data from a pair of preclinical studies delineating the role that cyclic guanosine monophosphate (cGMP) plays in alleviating intestinal pain. These studies demonstrate that cGMP inhibits intestinal pain in a preclinical model of intestinal hyperalgesia and desensitizes colonic afferent nerves in a similar model of experimental colitis. These results are from separate, ongoing collaborations with Dr. Michael Pezzone of the University of Pittsburgh's Division of Gastroenterology, Hepatology, and Nutrition and Dr. Lionel Bueno of the Neuro-Gastroenterology & Nutrition Unit at the National Institute for Agricultural Research (INRA) in Toulouse, France. Drs. Pezzone and Bueno presented these studies at the American College of Gastroenterology (ACG) 2008 Annual Scientific Meeting in Orlando, Fla. yesterday and today respectively.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081006/NEM080ALOGO )

Ironwood is actively exploring the role of cGMP in the control of intestinal function and is currently developing therapeutic agents that act through this mechanism. Ironwood's first cGMP modulator, linaclotide, acts in the intestine to increase intracellular and extracellular cGMP levels by stimulating guanylate cyclase C. Linaclotide is currently being evaluated in a comprehensive Phase 3 program by Ironwood and its partner Forest Laboratories for its potential to treat irritable bowel syndrome with constipation (IBS-C) and other gastrointestinal disorders. In a Phase 2b study in patients with IBS-C, linaclotide reduced abdominal pain and improved bowel habits. The detailed Phase 2b IBS-C study results will be presented tomorrow in a plenary session at ACG by Jeffrey M. Johnston, M.D., F.A.C.P.,
'/>"/>

SOURCE Ironwood Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
2. Ironwood and Forest to Present Positive Data From Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference
3. Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, United States Dental Devices Market ...reportlinker.com/p0158733/United-States-Dental-Dev..., United States Dental Devices Market Analysis ...eport is an essential source for in-depth informat...
(Date:11/25/2009)...Nov. 25 Swissray International, In...raphy ( ddR ) systems, announced today that its op...estor with a long term view towards growing Swissr...ed all assets and intellectual property, as well a...ss and growth Swissray is now poised to move to th...
(Date:11/25/2009)...v. 25 Cempra Pharmaceuticals Inc. ...ent and chief executive officer, will present at t...e at 8:50 a.m. EST, December 1, 2009, at The New Y...will provide an overview of the company,s two lead... of drug-resistant pathogens including MRSA. ,,...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2In Response to SEIU Lawsuit Judge Orders State to Halt Wage Cut For California Home Care Workers 50134 1Verathon Recognized Third Year in a Row as Outstanding Workplace in Washington State 50132 1Verathon Recognized Third Year in a Row as Outstanding Workplace in Washington State 50132 2AAHSA Statement on Long Term Services and Supports CBO Scoring 50130 1
... Feb. 23 People who start smoking before age 17...clerosis (MS), according to a study released today... Neurology,s 61st Annual Meeting in Seattle, April...ople with MS who were among more than 30,000 peopl...ed into three groups: non-smokers, early smokers (...
.... 23 /PRNewswire-FirstCall/ - Spectral Diagnostics...new findings demonstrating the clinical utility of...A cleared diagnostic for the measurement of endoto...mia congress. The conference took place in Tokyo, ...on the role of endotoxemia in sepsis. In addition ...
Other Medicine Technology:Young Smokers Increase Risk for Multiple Sclerosis 2Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan 2
(Date:11/26/2009)...sequestering drug tetrathiomolybdate (TM) has been... of Wilson disease, a disease caused by an overloa...much is known. Very little, however, is known abou... new study led by Northwestern University research...-dimensional structure of TM bound to copper-loade...
(Date:11/26/2009)...gger thrill when on an emotional rollercoaster, st...ay News) -- Call it the fear factor meets the jubi...ectators -- especially those who root for the winn...s a closely contested match and victory was in dou..., Chew on that this Thanksgiving weekend as you...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again ...n Dallas , is one of a growing number of physician...orking sites to connect with individuals who are i...ht morbid obesity. Dr. Kim is utilizing Facebook t...out his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a hig...ystem for retailers struggling to make an economic...mber 26, 2009 -- Flu fears is the type of challeng...gency room, according to Dr. David Benton, busines...usiness growth system – The Rfactor Intensi...
(Date:11/25/2009)...DINA, Minn., Nov. 25 Wh... their dentist. But a chiropractor can also give ...mporal-Mandibular Joint, which is where your jaw (...ral bone). ,, The most common symptoms associa...icking or popping of the jaw. But many other symp...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...tate-of-the-art eye care facility in Tanzania to,b...tion Award, BERKELEY, Calif., Nov. 5 Today, Seva...two pioneering leaders in,the fight against preven...,which Courtright and Lewallen established in 2001...
...rican Heart,Association and its Pharmaceutical Rou... for the Outcomes Research Centers initiative. The... and stroke research focusing on,the end results, ...ican,Heart Association national board member David...
...center research team, led by Columbia University M...o the cause of stomach cancer the second leading ...e team described for the first time, that elevated...ch cancer. These results are published in the Nov....
...problems in mice, researchers found , , WE...port that huge doses of an ordinary vitamin appear...odent equivalent of Alzheimer,s disease. , At the ... study, and scientists aren,t ready to recommend t...
... to talk sex secrets, one night stands and condoms...e,Foundation and SpinVox have teamed up with Lapen...ur TV show to promote sexual health amongst,young ...HIV/AIDS. Young people can interact with the campa...
...ok forward to health system reform in 2009, WASHI...cy Nielsen, M.D., AMA President:, "The American M...arack,Obama on his successful bid for the presiden...shares President-elect Obama,s focus on expanding ...
Other Medicine News:Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 2Health News:Seva Foundation Recognizes Paul Courtright and Susan Lewallen for Their Commitment to Blindness Prevention 3Health News:Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke 2Health News:Researchers describe how chronic inflammation can lead to stomach cancer 2Health News:Researchers describe how chronic inflammation can lead to stomach cancer 3Health News:Vitamin Holds Promise for Alzheimer's Disease 2Health News:Stars to 'Tell It Like It Is' at MTV's European Music Awards 2Health News:Stars to 'Tell It Like It Is' at MTV's European Music Awards 3Health News:AMA Congratulates President-Elect Obama 2
Inorganic Phosphorus UV Reagent Set
Phosphorus Reagent
Amylase (EPS-G7, kinetics)
Amylase (Colorimetric Method)
Medicine Products: